Group 1 - A class action lawsuit has been filed against Navan, Inc. on behalf of investors who purchased shares during the Class Period from October 28, 2025, to February 23, 2026, including those from the October 2025 IPO [1][2] - The lawsuit is based on allegations that Navan's IPO documents were misleading, particularly regarding undisclosed increases in "sales and marketing" expenses at the time of the IPO [3] - Following the revelation of the true state of the company's business, Navan's share price fell significantly, trading as low as $9.01 per share, which represents a decline of over 60% from the IPO price of $25 per share [3] Group 2 - Investors who acquired Navan securities during the Class Period have until April 24, 2026, to seek appointment as lead plaintiff representatives [2] - Navan, headquartered in Palo Alto, California, specializes in providing booking and expense reporting software for business travelers [2]

Core Viewpoint - A class action has been filed against Navan, Inc. (NASDAQ: NAVN) for allegedly misleading investors during its IPO on October 31, 2025, where shares were priced at $25 each [1][2]. Group 1: Company Overview - Navan, Inc. provides booking and expense reporting software for business travelers [1]. - The company reported a revenue growth of 33% year-over-year from 2024 to 2025 and a Gross Booking Volume (GBV) growth of 32% during the same period [2]. Group 2: Allegations and Financials - The complaint alleges that Navan increased its sales and marketing expenses by 39% in the quarter ending October 31, 2025, amounting to $95 million, compared to $68.5 million in the previous quarter [3]. - Following the emergence of these facts, Navan's shares fell to as low as $9.20, representing a decline of nearly 63% from the IPO price [3]. Group 3: Class Action Participation - Shareholders interested in participating as lead plaintiffs must submit their papers by April 24, 2026 [4]. - Shareholders can remain absent class members without participating in the case and still be eligible for recovery [4].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of Boston Scientific Corporation stockholders, alleging that the company misled investors regarding its business operations, particularly in the U.S. Electrophysiology segment, leading to a net income miss and disappointing guidance for the first half of fiscal 2026 [1]. Group 1: Allegations and Lawsuit Details - The class action lawsuit covers stock purchases made between July 23, 2025, and February 3, 2026 [1]. - The lawsuit claims that Boston Scientific's management was aware that the growth rate of its U.S. Electrophysiology segment was unsustainable, yet continued to make positive statements to investors [1]. - Investors were reportedly surprised by the company's net income miss and underwhelming guidance due to the misleading statements made by the defendants [1]. Group 2: Participation and Representation - Shareholders interested in serving as lead plaintiffs must file motions with the court by May 4, 2026 [1]. - Participation in the lawsuit is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [1]. - Rosen Law Firm operates on a contingency fee basis, meaning shareholders incur no fees or expenses unless they recover losses [1].

Core Viewpoint - A class action has been filed against Navan, Inc. for allegedly misleading investors during its IPO on October 31, 2025, where shares were priced at $25 each [1][2]. Financial Performance - Navan reported a revenue growth of 33% year-over-year from 2024 to 2025 and a Gross Booking Volume (GBV) growth of 32% during the same period [2]. - The company's "usage yield" was approximately 7% for both years [2]. Allegations - The complaint alleges that Navan increased its "sales and marketing" expenses by 39% in the quarter ending October 31, 2025, amounting to $95 million, compared to $68.5 million in the previous quarter [3]. - Following the revelation of these expenses, Navan's share price fell to as low as $9.20, representing a decline of nearly 63% from the IPO price [3]. Class Action Participation - Shareholders interested in serving as lead plaintiffs must submit their papers by April 24, 2026, but participation is not required to be eligible for recovery [4].

Core Viewpoint - A class action lawsuit has been filed against Navan, Inc. for allegedly misleading investors during its IPO on October 31, 2025, where shares were priced at $25 each [1] Group 1: Allegations and Financial Performance - The lawsuit claims that Navan's IPO documents stated the company had "experienced rapid growth," with a revenue increase of 33% year-over-year from 2024 to 2025 and a Gross Booking Volume (GBV) growth of 32% in the same period [1] - The company reported a "usage yield" of approximately 7% for both years [1] - However, it is alleged that Navan increased its "sales and marketing" expenses by 39% in the quarter ending October 31, 2025, amounting to $95 million, compared to $68.5 million in the previous quarter [1] Group 2: Impact on Stock Price - Following the emergence of these facts, Navan's stock price fell sharply, trading as low as $9.20 per share, which is nearly 63% below the IPO price of $25 [1] Group 3: Legal Proceedings - Shareholders wishing to serve as lead plaintiffs in the class action must submit their papers by April 24, 2026 [1] - Participation in the case is not required to be eligible for recovery, and all representation is on a contingency fee basis [1]

Core Viewpoint - A class action lawsuit has been filed against Navan, Inc. for allegedly misleading investors regarding its IPO documents, particularly concerning undisclosed increases in sales and marketing expenses [1][3]. Group 1: Lawsuit Details - The lawsuit is initiated by Berger Montague PC on behalf of investors who acquired Navan shares from October 28, 2025, to February 23, 2026, including during the IPO [1][2]. - Investors have until April 24, 2026, to seek appointment as lead plaintiff representatives [2]. Group 2: Financial Impact - Navan's shares have seen a significant decline, trading as low as $9.01 per share, which represents a drop of over 60% from the IPO price of $25 per share [3]. - The decline in share price has resulted in substantial losses for investors as the true state of the company's business was revealed [3]. Group 3: Company Overview - Navan, headquartered in Palo Alto, California, specializes in booking and expense reporting software for business travelers [2].

Core Viewpoint - Robbins LLP has filed a class action on behalf of investors who purchased Navan, Inc. (NASDAQ: NAVN) securities in connection with its IPO, alleging that the company misled investors regarding its financial performance and growth prospects [1][2]. Group 1: Allegations and Financial Performance - Navan conducted its IPO on October 31, 2025, at a price of $25 per share, claiming rapid growth and a diverse customer base [2]. - The company's revenue grew by 33% year-over-year from 2024 to 2025, and its Gross Booking Volume (GBV) increased by 32% during the same period [2]. - However, it was revealed that Navan had increased its sales and marketing expenses by 39% for the quarter ending October 31, 2025, amounting to $95 million, compared to $68.5 million for the previous quarter [3]. Group 2: Impact on Share Price - Following the emergence of these facts, Navan's shares fell sharply, trading as low as $9.20 per share, which is nearly 63% below the IPO price of $25 [3]. Group 3: Class Action Participation - Shareholders wishing to serve as lead plaintiffs in the class action must submit their papers by April 24, 2026, but participation is not required to be eligible for recovery [4].